High levels of miR-106a in G1 endometrial cancer and overexpression of PKD2 may indicate that the potential regulation of expression does not occur directly, and perhaps the activity of elements modulating the normal level of PKD2 is suppressed. This evidence concerns the gene PKD2 and endometrial cancer.